A detailed history of Zions Bancorporation, N.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 2,871 shares of ABT stock, worth $329,475. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,871
Previous 5,078 43.46%
Holding current value
$329,475
Previous $527,000 37.95%
% of portfolio
0.02%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$100.07 - $118.13 $220,854 - $260,712
-2,207 Reduced 43.46%
2,871 $327,000
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $561,166 - $626,403
-5,571 Reduced 52.31%
5,078 $527,000
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $72,721 - $80,317
664 Added 6.65%
10,649 $1.21 Million
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $223,490 - $273,571
-2,478 Reduced 19.88%
9,985 $1.1 Million
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $211,503 - $253,768
-2,214 Reduced 15.08%
12,463 $1.21 Million
Q2 2023

Jul 28, 2023

SELL
$100.78 - $112.29 $23,784 - $26,500
-236 Reduced 1.58%
14,677 $1.6 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $464,928 - $547,248
4,800 Added 47.46%
14,913 $1.51 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $363,509 - $426,452
-3,824 Reduced 27.44%
10,113 $1.11 Million
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $33,478 - $38,762
-346 Reduced 2.42%
13,937 $1.35 Million
Q2 2022

Aug 05, 2022

SELL
$102.07 - $123.37 $90,229 - $109,059
-884 Reduced 5.83%
14,283 $1.55 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $207,516 - $253,052
1,820 Added 13.64%
15,167 $1.8 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $108,829 - $133,255
942 Added 7.59%
13,347 $1.88 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $118,059 - $130,608
1,012 Added 8.88%
12,405 $1.47 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $324,775 - $382,307
3,070 Added 36.89%
11,393 $1.32 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $447,876 - $527,666
4,115 Added 97.79%
8,323 $997,000
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $101,535 - $110,644
-967 Reduced 18.69%
4,208 $461,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $1,741 - $2,114
19 Added 0.37%
5,175 $563,000
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $63,323 - $81,046
-827 Reduced 13.82%
5,156 $471,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $117,284 - $171,502
-1,867 Reduced 23.78%
5,983 $472,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $8,714 - $9,701
-111 Reduced 1.39%
7,850 $682,000
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $651,528 - $706,459
7,961 New
7,961 $666,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.